A homozygous intronic splice-acceptor mutation in ANO6 (Anoctamin 6) resulting in a premature stop codon has been identified in a patient with Scott syndrome, a bleeding disorder defined by reduced surface exposure of procoagulant phosphatidylserine (PS) on blood cells as a consequence of activation with Ca2+-elevating agents [92]. The gene discussed is ANO6; the disease is Scott syndrome.